Many of you may be aware of an article published in the Lancet on the eighth of September. ‘Interpretation of the evidence for the efficacy and safety of statin therapy.’It caused a media stir, and I was asked to appear on a few BBC programmes to argue against it – tricky in two minutes. At one stage I was cut off when I attempted to bring up the issue of financial conflicts of interest amongst the authors. The lead author of this paper was Professor Sir Rory Collins.
In truth, I have been awaiting this article for some time. In fact, I am going to reproduce here a blog I wrote on February 16, 2015, predicting exactly what was going to happen, who was going to be involved, and (in broad terms) exactly what they were going to say.